I. Introduction
Diabetes is a significant illness that is on the rise all over the world. InIndia, the incidence of diabetes is increasing at an alarming rate. There were 24 million diabetics in the year 2000 and this figure is expected to reach 57.2 million by 2025. India leads the world today with largest number of diabetic patients in any given country. [1] Prevalence, severity and extent of periodontal disease are higher in patient with diabetes mellitus (DM) than in non diabetic control. [2] [3] [4] [5] [6] [7] In patients with diabetes mellitus (DM),accumulation of AGEs (Advance Glycated end Products) increases periodontal disease severity [9, 37] by upregulation of proinflammatory cytokines from monocytes/polymorphonuclear leukocytes and down regulation of growth factors from macrophages. [9] Periodontal attachment loss increased in diabetic patients because of degradation of collagen fibres by MMPs (MMP- 8 & 9) , which are elevated in diabetic tissues, including the periodontium. Impaired osseous healing and bone turnover also seen in association with hyperglycemia. [11, 12] In individuals with type-2 diabetes, who already has insulin resistance, further tissue resistance to insulin induced by infection like periodontitis may considerably exacerbate poor glycemic control. [8] Among various methods of measurement of glycemic control,HbA 1C assay is a glucose assay, which doesn't require fasting, doesn't rely on patient compliance & gives indication of blood glucose level over an extended period of time. HbA 1C assay, is based on the knowledge -blood glucose becomes slowly, nonenzymatically& irreversibly bound to hemoglobin molecules. [14, 36] HbA 1C is the component resulting from post translational modification of HbA by glucose at the N -terminus of β chain. Glycosylated Hemoglobin (GHb) is a general term for glucose bound nonenzymatically to hemoglobin with a ketoamine structure. Sincethe average life span of RBCs is 120days, the HbA 1C assay will reveal patient's glucose status over the [14, 15] Although many studies have examined the effect of diabetes on periodontium, fewer have endeavored to examine the effect of periodontal infection on control of diabetes. [16-19, 33, 34] Data suggest, treatment of chronic periodontitis improve glycemic status of diabetic. [20, 21] Present study focuses over the clinical and metabolic status in type-2 diabetics after non-surgical periodontal therapy.
II. Materials And Methods
Present study was a prospective, parallel, comparative, longitudinal clinical study & carried out for management of periodontal infection in experimental group with type 2 diabetics and control group with non diabetics. 4 . Pregnancy or intention to be pregnant during the 6 months of study.
Selection

Sample size :
After applying the inclusion and exclusion criteria two groups of patients consecutively selected : 20 patient, with type 2 diabetes visiting diabetes OPD, Department of Medicine Civil Hospital Ahmedabad having periodontal disease were selected as an experimental group and 10 patients, with Moderate Chronic Generalized Periodontitis came to OPD of Dept. of Periodontology, Govt. Dental college & hospital Ahmedabad were selected as a control group.
Clinical assessment
Clinical assessment had been done by using plaque Index (TURESKY -GILMORE -GLICKMAN MODIFICATION OF THE QUIGLEY-HEIN PLAQUE INDEX), gingival Bleeding Index (GBI) of Ainamo and Bay, probing depth and clinical attachment level in mm measured by UNC 15 probe.
Blood Investigation
Venous blood samples were collected & assessed for Fasting blood glucose & HbA1c, at baseline and after 3 months & 6months of completion of treatment . Fasting blood sugar done by O -toludin method . Estimation of HbA1c was done by Chromatographic spectrophotometric ion exchange method. Blood investigations were done in Diabetes Research Centre, BJ Medical College Ahmedabad.
Treatment Regimen
Conventional Periodontal treatment scaling and root planning under local anesthesia (if necessary) in 4 sessions. Maximum time interval between each session of scaling and root planning should be 4 weeks. 
III. Results
IV. Discussion
Present study was a prospective, parallel, comparative longitudinal clinical study. Very strict inclusion and exclusion criteria were applied to minimize confounding factors. Our aim of present study was that after control over periodontal infection by conventional periodontal treatment -scaling and root planning (without any adjunctive antimicrobials), to evaluate clinical & metabolic status by means of improvement in blood HbA1c level & with clinical variables (plaque index, bleeding index, probing depth, clinical attachment level) in type-2 diabetics in comparison to non diabetics after 3 & 6 months.
HbA 1c assay, is a glucose assay as a metabolic parameter to check diabetes status of experimental population used worldwide in the field of periodontology. [ 9, 10, 20, 21] Specificity of HbA 1c assay is 83 to 89% & sensitivity of HbA 1c assay is 45 to 90%. [14] . The metabolic assessment was based on blood levels of HbA 1c andFasting blood glucose. The ADA (American Diabetic Association) recommends fasting Plasma glucose (FPG) as the screening test of choice. 26 In the present study obtained results of HbA1c were converted in to equivalent to a US National Glycohemoglobin Standardization Programme(NGSP) & Diabetes control & trial research group(DCCT), using the following formula: %HbA1c-NGSP = 0.86 × %HbA1c -Biosystems + 0.24 This formula eliminates the chances of variation & increases accuracy of results in present study. Fructosamine and albumin levels have also been used for this purpose in some previous studies. [23] found that fructosamine assaycorrelated with the degree of gingival bleeding.
Furthermore, comparison of results of present study with published data must take into account the inclusion of a matched control group. The studies by Grossi et al.(1997) [16] and Stewart et al. (2001) 17] did not include a control group of non diabetic patients. At the beginning of present study , no statistically significant difference were observed between the diabetic and control groups in age, gender, number of teeth present.
The current study, utilizing non-surgical periodontal therapy [25] [26] [27] , showed a significant reduction in infection and periodontal inflammation, in both diabetic& control group, as well as reduced HbA1c levels after 3 & 6 months in diabetic group.
In present study, diabetic group plaque score reduction (Table-3 , Row :1) from baseline to 3 months 54% & from base line to 6 months 76%. In non-diabetic group plaque score reduction (Table-5 , Row :1),at all examinations p<0.0001, suggestive of highly significant improvement in both groups. The diabetic & control groups did not significantly differ in plaque index (P>0.3986) (Table-6, Row :1). In the study of RicardoFariaAlmeida, Ana Navarro, and Antonio Bascones (2006) [21] , statistically significant differences were observed in both groups between baseline and 6 months 68 % reduction in diabetic group & 70 % in non-diabetic group (P<0.0001). Present study also shows similaritis in results with Debora C. Rodrigues (2003) [20] and Grossi et al(1997) [16] in the plaque score reduction. In present study statistically significant difference observed in reduction of bleeding on probing at each interval in both the groups (p<0.0001) without significantly differ in between two groups (P>0.3546), favors the results in studies by Debora C. Rodrigues (2003) [20] , Grossi et al (1997) [16] , Christgau et al.(1998) [25] . Statistically significant differences (P<0.05) in mean probing depth reduction, were found between the two groups (Diabetic & control groups), with significantly (P<0.0343) better outcomes for the control group (Table-6, Row :3). However, both groups showed significant improvements (P<0.0001) at each follow-up examination. Baseline and 6 months 37% reduction in diabetic group & 44% in non-diabetic group (P<0.0001) ( Table-3, Row :3 & Table- 5, Row :3). The reduction in probing depth observed in study of Debora C.Rodrigues (2003) 20] was 25% after 3 months. Statistically significant differences in clinical attachment level were observed between the diabetic and control groups, with significantly (P<0.021) better outcomes for the control group (Table-5 , Row :4).
In present study at baseline Fasting Blood Sugar (FBS) in diabetic patients (Table-2 (Piche, Swan, Hallmon; [ . 14] In nondiabetic control group (Table-4 In present study reduction in HbA 1c level in diabetic group (Table-2 20 both groups showed reductions in HbA 1c levels. The change in HbA1c levels was 4% in G1 (one stage full mouth scaling & root planning plus amoxicillin/clavulanic acid 875 mg)and 11% in G2 (one stage full mouth scaling &root planning alone), with a statistically significant difference between groups by ANCOVA. Grossi et al. (1997) 16 obtained similar numbers after 3 months of a combined non-surgical periodontal therapy 17 in a retrospective study, evaluated patients who received scaling and root planning without antibiotics; after 10 months, glycated hemoglobin examinations were performed and revealed an average reduction of 17% from baseline HbA1c levels. HbA 1c level in non-diabetic control group (Table-4 & 5 , METABOLIC  PARAMETERS Row : 2) was at baseline 6.6±0.32, after treatment at 3 months 6.4±0.4,after treatment at 6 months 6.02±0.23. This also shows non-diabetic status of control group in comparison with diabetic group through out the study.
V. Conclusion
In present study, both the groups show statistically significant improvement in all the clinical variables at each follow-up examination, with statistically significant better outcomes for control group in probing depth & clinical attachment level. The diabetic patients showed statistically significant improvement in their metabolic control from baseline to 3 and 6 months as measured by HbA 1c levels (p< 0.0001) after conventional periodontal therapy. Therefore, we can conclude, non surgical conventional periodontal treatment can improve glycemic status of type-2 diabetics with chronic generalized periodontitis. Tables  TABLE-1 
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